Skip to content

Efficacy analysis of 2D-shear wave elastography combined with preoperative hematological indicators in assessing liver fibrosis

Efficacy analysis of 2D-shear wave elastography combined with preoperative hematological indicators in assessing liver fibrosis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039660
Enrollment
Unknown
Registered
2020-11-04
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver fibrosis

Interventions

Gold Standard:Pathologic diagnosis
Index test:A&#32
predictive&#32
model&#32
for&#32
based&#32
on&#32
the&#32
results&#32
of&#32
imaging&#32
and&#32
hematological&#32

Sponsors

Zhongshan Hospital, Fudan university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-80 years old, men and women are not limited; (2) ECOG score is 0-1; (3) No history of cerebrovascular accident or renal insufficiency; (4) No other malignant tumor disease history; (5) A history of hepatitis B without antiviral treatment; (6) Preoperative imaging examination suggested HCC and aim to undergo radical surgical treatment.

Exclusion criteria

Exclusion criteria: (1) Failure to obtain informed consent; (2) Tumor cannot be surgically removed; (3) Accompanied by other systemic malignant primary tumors; (4) Pregnant women.

Design outcomes

Primary

MeasureTime frame
Liver stiffness;SEN, SPE, ACC, AUC of ROC, PPV, NPV;

Countries

China

Contacts

Public ContactWang Zheng

Zhongshan Hospital, Fudan University

wzdoc@163.com+86 21-64041990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026